Scientists from the Cleveland Clinic and Cornell University have created a computational tool that uses AI to understand how genetic mutations affect protein-protein interactions in diseases such as cancer. The software, called PIONEER, could help accelerate drug development and clinical trials by targeting specific protein-protein interactions. The system uses data from nearly 100,000 individuals with disease-causing mutations and information about almost 300,000 protein pair interactions.
Top 10 Best Privileged Access Management (PAM) Solutions 2026
In the dynamic and increasingly complex cybersecurity landscape of 2026, privileged accounts remain the most coveted targets for cybercriminals and malicious insiders alike. From system
.webp?w=0&resize=0,0&ssl=1 "Top 10 Best User Access Management Tools in 2026")
